Skip to main content
Clinical Trials/NCT02294071
NCT02294071
Unknown
Phase 4

Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children

Lawson Health Research Institute0 sites120 target enrollmentDecember 2014

Overview

Phase
Phase 4
Intervention
Acetaminophen
Conditions
Fever
Sponsor
Lawson Health Research Institute
Enrollment
120
Primary Endpoint
temperature reduction from baseline
Last Updated
11 years ago

Overview

Brief Summary

This study will examine in detail the immediate effects of three common treatments given to children with fevers to lower their temperature. Each child will be given either ibuprofen, acetaminophen, or a combination, and their temperature monitored at five-minute intervals. The temperature-lowering effects of each treatment will be compared to evaluate which is most effective.

Detailed Description

There is no substantial evidence that a fever lower than 41°C is harmful to the welfare of an otherwise healthy child, although they can be dangerous to children already in critical condition \[1,2\]. However, fevers in healthy children commonly cause anxiety in parents and caregivers, so parents and physicians often give antipyretic medications to lower the fever \[3,4\]. Ibuprofen and acetaminophen are two of the most commonly used medications in children. Most major pediatric medical associations agree about appropriate dosages for children, but give no clear guidelines on whether ibuprofen or acetaminophen should be used \[3,5\]. Physicians commonly make the decision between the two based on their personal opinions of the efficacy and safety of the medications, or based on habit \[6\]. Survey data shows that more than half of physicians use combinations of both acetaminophen and ibuprofen to treat fever, either simultaneously or on an alternating schedule, with a variety of dosing patterns \[6\]. A majority of physicians believed there were established guidelines supporting this use, but in fact there are not \[6\]. Combining the two medications is widely theorized to improve effectiveness, but clinical trials comparing combination treatments to ibuprofen and/or acetaminophen alone have shown inconsistent results \[4,7-12\]. Several pharmacodynamic studies have shown that ibuprofen and acetaminophen both produce their largest effects on temperature within the first hour following dosage \[9,10,13-16\]. Despite this, only one study has been performed examining the change in temperature at intervals shorter than 30 minutes, and that study used substandard monitoring methods \[10\]. This study will use gold-standard monitoring methods to take temperatures every five minutes through the first one to four hours of treatment. Understanding the pattern of temperature change in the acute stages after dosing will help settle the debate about the optimal medication choice for treating childrens' fevers.

Registry
clinicaltrials.gov
Start Date
December 2014
End Date
November 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Rieder

Principal Investigator

Lawson Health Research Institute

Eligibility Criteria

Inclusion Criteria

  • fever between 38 and 41 Celsius (inclusive) on presentation to ER
  • assessment by treating physician that patient requires antipyretic treatment

Exclusion Criteria

  • known allergy or hypersensitivity to either study medication
  • received any antipyretic medication in past eight hours
  • patient requires admission to hospital
  • co-morbidities indicating increased risk of complication
  • assessment by treating physician that patient is medically unsuitable for the study

Arms & Interventions

acetaminophen

acetaminophen 15mg/kg (max 975mg)

Intervention: Acetaminophen

ibuprofen

ibuprofen 10mg/kg (max 600mg)

Intervention: Ibuprofen

combination

acetaminophen 15mg/kg (max 975mg) and ibuprofen 10mg/kg (max 600mg)

Intervention: Ibuprofen

combination

acetaminophen 15mg/kg (max 975mg) and ibuprofen 10mg/kg (max 600mg)

Intervention: Acetaminophen

Outcomes

Primary Outcomes

temperature reduction from baseline

Time Frame: 4 hours

change in temperature from baseline at time of drug administration and at five minute intervals afterward for a minimum of one hour, maximum 4 hours

Similar Trials

Completed
Phase 4
Influenza Vaccine in Pediatric Transplant SubjectsInfluenza
NCT00133510National Institute of Allergy and Infectious Diseases (NIAID)60
Terminated
N/A
Effectiveness of the Astym Technique, the Graston Technique, and Therapeutic Ultrasound in the Treatment of Lateral Epicondylosis.Lateral EpicondylitisTennis ElbowPosterolateral Rotator Instability
NCT03234192NYU Langone Health21
Completed
N/A
Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological DeficitThoracic Spine FractureLumbar; Spine, FractureThoracolumbar Burst FractureFracture of Spine, Level UnspecifiedSpine FusionSpine Fracture
NCT06059820Sklifosovsky Institute of Emergency Care40
Completed
N/A
Treat Arterial Hypertension and Diabetes in Rural AfricaDiabetesArterial Hypertension
NCT00744458Cooperation Afrique223
Completed
Phase 3
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeChildhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Monoblastic Leukemia (M5a)Childhood Acute Monocytic Leukemia (M5b)Childhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Childhood Acute Myelomonocytic Leukemia (M4)Childhood Myelodysplastic SyndromesChronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromesRefractory AnemiaRefractory Anemia With Excess BlastsRefractory Anemia With Excess Blasts in TransformationRefractory Anemia With Ringed SideroblastsSecondary Myelodysplastic SyndromesUntreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
NCT00002798National Cancer Institute (NCI)880